DrugClass

Webinar: COVID-19 antivirals — where are we now?

A panel of experts discuss the use of antivirals for the treatment of COVID-19, with consideration for the current landscape and future variants in this webinar recording.…

Supported content

Rapid-acting antidepressants face a slow journey to wider use

Evidence is mounting for the effectiveness of rapid-acting antidepressants for treatment-resistant depression — but will their use ever take off in the NHS?…

Improving safety of warfarin prescribing and administration using clinical decision support

There are several benefits of electronic prescribing and medication administration (EPMA) systems, including the ability to support the reduction in medication omission errors[1,2]. Researchers suggest that medication administration errors account for ju…

Case-based learning: safe withdrawal and tapering of antidepressants

How to use hyperbolic tapering to avoid withdrawal effects when stopping an antidepressant.…

Improving asthma care for children and young people

Considerations for pharmacists in helping young patients manage their asthma.…

E-cigarettes associated with greatest chance of smoking cessation, suggests Cochrane review

The review revealed that 10–19% of people were likely to quit smoking using an e-cigarette, 12–16% using varenicline and 10–18% using cytisine.…

Shortage of scabies treatment ‘likely to become a major public health issue’

The government has issued a medicine supply notification warning that permethrin 5% w/w cream will be “in limited supply until further notice due to an increase in demand”.…

Every community pharmacy in Scotland to stock emergency supplies of naloxone from October 2023

The naloxone emergency supply service will be added to the community pharmacy public health service in Scotland from 30 October 2023.…

How to approach challenging scenarios in primary care pharmacy

Three examples of vulnerable patients and those at risk of harm. The featured scenarios consider themes of suicide, addiction and sexual violence.…

‘Blanket switch’ to greener inhalers not recommended in prescribing guidance

The Scottish government has published a consultation on draft guidance emphasising that patients should only be switched to greener inhalers “if effectiveness, safety or adherence is not compromised”.…